fbpx Skip to content

‘First-ever’ reproductive insurance startup Juniper raises £1.5m

Image credit: Peakstock / Shutterstock

Insurance startup Juniper has raised £1.5m in a pre-seed funding round for what it calls the “first-ever” coverage for reproductive organs.

Founded in 2023, Juniper is a new insurance provider looking to address the gap in comprehensive genital insurance in the healthcare market.

Research from Imperial College London found that in the UK, one in three women have reported a reproductive or gynaecological health problem. A study from Western Michigan Urological Associates found that one in four men experience low testosterone by age 30.

Juniper claims that the prevalence of genital issues is not being met by appropriate insurance coverage.

“I was diagnosed with polycystic ovarian syndrome early on, and my corporate health insurance didn’t cover it, as PCOS was classified as a chronic reproductive condition,” said co-founder and CEO Ambra Zhang.

Zhang said she would have to pay thousands “out of pocket” to secure the prescription she needed.

“Juniper bridges this gap by providing end-to-end reproductive health support for employees and offers tailored, high-quality insurance products for employers and brokers,” Zhang said.

“Our digital platform aims to revolutionise the insurance industry by meeting the unmet needs of the new generation.”

The Juniper platform offers access to testing and routine check-ups, medical education, community support, care navigation and medical reimbursement. Juniper is targeting medium to large enterprises looking to provide reproductive coverage for employees.

The funding round was led by Insurtech Gateway and featured participation from 2100 Ventures, Exceptional Ventures and Heartfelt Ventures.

“When Juniper asked us to imagine dental insurance, but for your genitals, it opened our eyes to a substantial market largely ignored by traditional insurance,” said Robert Lumley, co-founder of Insurtech Gateway.

“Juniper is removing the stigma surrounding reproductive health issues and enabling employers to offer comprehensive care for all employees.”

Additional funding came from a handful of angel investors.